EXAMS · SÃO PAULO
In situ hybridization (CISH and SISH): cost, procedure, and prep
An advanced molecular technique locates genetic changes directly in the cells of your biopsy to guide treatment decisions.

Understand the exam
When assessing the HER2 gene, while immunohistochemistry remains the initial screening method, in situ hybridization techniques are essential to clarify equivocal cases and provide a quantitative assessment of HER2 gene status. In situ hybridization locates specific nucleic acid sequences (DNA or RNA) in cells or tissues through complementary binding of a molecular probe to the target sequence being investigated.
The clinic lists two options: "in situ" hybridization (CISH) and "in situ" hybridization (SISH). Both are evaluated using bright-field microscopy, and the difference lies in signal development: CISH uses organic chromogens, while SISH uses silver-based enzymatic metallography, producing distinctly different signals for analysis.
How it is done
In the laboratory, a probe is applied to sections of formalin-fixed, paraffin-embedded tissue, and a chromogenic enzymatic reaction is performed to visualize permanent signals using bright-field microscopy.
According to the clinic's listing, both the CISH and SISH options have a recorded duration of 10 minutes for receiving and checking the material, with no physical preparation or fasting required. When you book, the team explains which previous reports and paraffin blocks you should bring.
When it is recommended
- Confirmation of HER2 gene amplification in breast carcinomas when immunohistochemistry has an equivocal score (2+)
- Testing for genetic rearrangements to help diagnose lymphomas and other neoplasms
- Investigation of Epstein-Barr virus (EBV) in neoplasms, such as detecting viral genome targets in cervical carcinoma samples
- Identification of human cytomegalovirus (CMV) infection in histological sections of formalin-fixed, paraffin-embedded biopsies
Does the exam hurt?
For HPV detection in cervical samples, in situ hybridization has proved to be a reproducible method in archived tissue, allowing assessment even years after sample collection.
Cost and health plans
| Exam | Self-pay | Duration | Health plans |
|---|---|---|---|
| “In situ” hybridization | Starting at R$ 735.00 (≈ US$ 129, estimated) | 10 minutes | Ask the team about coverage |
The team confirms the requested option, coverage, and conditions before booking.
Book an examFrequently asked questions
What is the difference between the listed CISH and SISH options?
Both "in situ" hybridization (CISH) and "in situ" hybridization (SISH) emerged as promising alternatives for in situ hybridization using bright-field microscopy. The difference lies in signal development: CISH uses organic chromogens, while SISH uses silver-based enzymatic metallography, producing distinctly different signals for analysis.
Do I need a new biopsy for the test?
Chromogenic in situ hybridization (CISH) can also be used on formalin-fixed, paraffin-embedded tissue. The team confirms delivery of this material when you book.
How long does the exam take and what preparation is needed?
The clinic's listing specifies 10 minutes for both options (for checking and registering the sample) and lists no preparation. The team explains everything when you book.
What is the difference between in situ hybridization and immunohistochemistry?
When assessing the HER2/neu marker, immunohistochemistry is recommended to detect protein overexpression, while in situ hybridization is recommended to detect gene amplification.
How long does it take to get the results?
The listing does not specify a turnaround time on the page, and the team provides the delivery date at your visit.
Does my health plan cover in situ hybridization?
Coverage depends on your plan's guidelines and the clinical indication on the doctor's order. When you book, the team confirms coverage with your health plan.
Where we see patients
References
- Todorović-Raković N. Chromogenic In Situ Hybridization (CISH) as a Method for Detection of C-Myc Amplification in Formalin-Fixed Paraffin-Embedded Tumor Tissue: An Update. Methods Mol Biol. 2021.
- Badawy W. Computational methods, clinical evidence, and translational readiness for artificial intelligence for HER2 assessment using silver in situ hybridization (SISH). Breast Cancer Res. 2026.
- Monné Rodríguez JM, Frisk AL, Kreutzer R, et al. European Society of Toxicologic Pathology (Pathology 2.0 Molecular Pathology Special Interest Group): Review of In Situ Hybridization Techniques for Drug Research and Development. Toxicol Pathol. 2023.
- Braun M, Stomper J, Boehm D, et al. Improved method of detecting the ERG gene rearrangement in prostate cancer using combined dual-color chromogenic and silver in situ hybridization. J Mol Diagn. 2012.
- Pehlivanoglu B, Serin G, Yeniay L, et al. Comparison of HER2 status determination methods in HER2 (2+) patients: Manual fluorescent in situ hybridization (FISH) vs. dual silver enhanced in situ hybridization (SISH). Ann Diagn Pathol. 2017.
- Luk PP, Selinger CI, Cooper WA, et al. Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms. Head Neck Pathol. 2019.
- Silva ÁDL, Marelli JGA, Lira Lopes MW, et al. Epstein-barr virus (EBV) in cervical carcinoma detected by in situ hybridization targeting ebers and the viral genome. Braz J Microbiol. 2025.
- Rangel JV, Coelho JMCO, Rioja LDS, et al. Validation of an automated chromogenic in situ hybridization protocol for detection of cytomegalovirus in formalin-fixed, paraffin-embedded renal graft biopsies. J Bras Nefrol. 2026.
- Przybylski M, Millert-Kalińska S, Pruski D, et al. Detection of HPV DNA in Cervical Intraepithelial Neoplasia Using In Situ Hybridization. J Clin Med. 2026.
- Ali AHM, Yahya AQ, Mohammed HL. Chromogenic in Situ Hybridization Technique versus Immunohistochemistry in Assessment of HER2/neu Status in 448 Iraqi Patients with Invasive Breast Carcinoma. Open Access Maced J Med Sci. 2019.
This content is informational and does not replace a consultation.
Updated on